Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
|
+$465M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$268M |
| 3 |
Verizon
VZ
|
+$239M |
| 4 |
Microsoft
MSFT
|
+$212M |
| 5 |
Apple
AAPL
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$421M |
| 2 |
Becton Dickinson
BDX
|
+$213M |
| 3 |
Home Depot
HD
|
+$191M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$132M |
| 5 |
Broadcom
AVGO
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.96% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.98% |
| 4 | Consumer Discretionary | 10.85% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
PetMed Express
PETS
$42.3M
| $11.1M | ﹤0.01% |
437,790
+43,173
| +11% | +$1.19M |
|
|
SPTN
1952
DELISTED
SpartanNash
SPTN
| $11M | ﹤0.01% |
427,809
+9,842
| +2% | +$237K |
|
|
SAGE
1953
DELISTED
Sage Therapeutics
SAGE
| $11M | ﹤0.01% |
259,034
+3,101
| +1% | +$130K |
|
1954
Chefs' Warehouse
CHEF
$4.54B
| $11M | ﹤0.01% |
329,780
+1,148
| +0.3% | +$37.9K |
|
1955
Perdoceo Education
PRDO
$2.04B
| $11M | ﹤0.01% |
933,399
+45,216
| +5% | +$493K |
|
1956
National Healthcare
NHC
$3.48B
| $11M | ﹤0.01% |
161,559
+6,137
| +4% | +$425K |
|
|
CWEN.A
1957
DELISTED
Clearway Energy Class A
CWEN.A
| $10.9M | ﹤0.01% |
325,394
+26,887
| +9% | +$883K |
|
1958
BRC Group Holdings
RILY
$301M
| $10.9M | ﹤0.01% |
122,173
+602
| +0.5% | +$44K |
|
1959
Revolution Medicines
RVMD
$38.8B
| $10.9M | ﹤0.01% |
431,078
+5,238
| +1% | +$148K |
|
1960
Protagonist Therapeutics
PTGX
$8.51B
| $10.8M | ﹤0.01% |
317,179
+7,347
| +2% | +$232K |
|
1961
FB Financial Corp
FBK
$3.05B
| $10.8M | ﹤0.01% |
247,224
+5,424
| +2% | +$243K |
|
1962
Delek US
DK
$4.05B
| $10.8M | ﹤0.01% |
721,977
+20,938
| +3% | +$370K |
|
1963
Hanmi Financial
HAFC
$949M
| $10.8M | ﹤0.01% |
455,411
+21,103
| +5% | +$471K |
|
1964
Supernus Pharmaceuticals
SUPN
$2.67B
| $10.8M | ﹤0.01% |
369,092
+7,087
| +2% | +$215K |
|
|
PENG
1965
Penguin Solutions Inc
PENG
$2.7B
| $10.7M | ﹤0.01% |
302,478
+4,224
| +1% | +$120K |
|
|
DENN
1966
DELISTED
Denny's
DENN
| $10.7M | ﹤0.01% |
670,910
+18,393
| +3% | +$282K |
|
1967
E.W. Scripps
SSP
$258M
| $10.7M | ﹤0.01% |
554,346
+4,718
| +0.9% | +$91.2K |
|
1968
US Physical Therapy
USPH
$1.18B
| $10.7M | ﹤0.01% |
111,764
+8,722
| +8% | +$874K |
|
1969
Huazhu Hotels Group
HTHT
$13.1B
| $10.6M | ﹤0.01% |
284,775
-1,015
| -0.4% | -$44.4K |
|
|
TWOU
1970
DELISTED
2U Inc
TWOU
| $10.6M | ﹤0.01% |
17,590
+463
| +3% | +$369K |
|
|
HSII
1971
DELISTED
Heidrick & Struggles
HSII
| $10.6M | ﹤0.01% |
241,714
+53,612
| +29% | +$2.44M |
|
1972
Quanterix
QTRX
$175M
| $10.6M | ﹤0.01% |
249,104
-588
| -0.2% | -$27.5K |
|
|
IMGN
1973
DELISTED
Immunogen Inc
IMGN
| $10.6M | ﹤0.01% |
1,421,923
+15,921
| +1% | +$98.9K |
|
1974
OceanFirst Financial
OCFC
$1.71B
| $10.5M | ﹤0.01% |
472,154
+59,157
| +14% | +$1.29M |
|
|
NBIS
1975
Nebius Group N.V.
NBIS
$54B
| $10.5M | ﹤0.01% |
173,106
+10,963
| +7% | +$808K |
|
Similar funds
Charles Schwab's Q4 2021 Portfolio in Review
As of Q4 2021, Charles Schwab held 3,647 positions worth $339B, up 11% from $306B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Charles Schwab's Q4 2021 filing shows 148 new, 2,572 increased, 501 reduced and 58 closed positions. Its largest new stake was Kyndryl: 2,951,149 shares worth $53.4M. The largest sale was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, an estimated $421M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2021 buy was Kyndryl: 2,951,149 shares worth $53.4M.
- Charles Schwab added most to State Street SPDR Portfolio Short Term Treasury ETF in Q4 2021, an estimated $465M increase.
- Charles Schwab's biggest Q4 2021 reduction was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, cutting an estimated $421M.
- Charles Schwab fully exited Kansas City Southern in Q4 2021, selling an estimated $113M.
- Charles Schwab's ten largest holdings make up 18% of its $339B portfolio in Q4 2021.
- Charles Schwab opened 148 new positions and closed 58 in Q4 2021.
- Charles Schwab's portfolio value rose 11% quarter-over-quarter to $339B.
Based on Charles Schwab's 13F filing for Q4 2021, filed 11 Feb 2022.